These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9879566)

  • 1. 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties.
    Rehse K; Brümmer U; Unsöld E
    Pharmazie; 1998 Dec; 53(12):820-4. PubMed ID: 9879566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.
    Rehse K; Ciborski T; Lüdtke E
    Arch Pharm (Weinheim); 1994 Dec; 327(12):771-7. PubMed ID: 7872854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
    Cwiklicki A; Rehse K
    Arch Pharm (Weinheim); 2004 Mar; 337(3):156-63. PubMed ID: 15038061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
    Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
    J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationships.
    Campillo N; Goya P; Páez JA
    J Med Chem; 1999 Aug; 42(17):3279-88. PubMed ID: 10464014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antithrombotics with an indazole structure.
    Yildiz AK; Rehse K; Stasch JP; Bischoff E
    Arch Pharm (Weinheim); 2004 Jun; 337(6):311-6. PubMed ID: 15188220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New NO-donors with antithrombotic and vasodilating activities, IX: Thiadiazole nitrosimines.
    Rehse K; Lüdtke E
    Arch Pharm (Weinheim); 1995 Jan; 328(1):17-20. PubMed ID: 7695468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
    Yao FM; Sun CS
    Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thienopyrimidine-based P2Y12 platelet aggregation inhibitors.
    Kortum SW; Lachance RM; Schweitzer BA; Yalamanchili G; Rahman H; Ennis MD; Huff RM; TenBrink RE
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5919-23. PubMed ID: 19748783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New NO-donors with antithrombotic and vasodilating activities, VI: thiazole-2-nitrosimines.
    Rehse K; Lüdtke E
    Arch Pharm (Weinheim); 1994 Sep; 327(9):581-9. PubMed ID: 7979924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
    Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
    J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New NO donors with antithrombotic and vasodilating activities, part 25. Hydroxylamine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Nov; 331(11):365-7. PubMed ID: 9881060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet and Antithrombotic Properties of Compound L-36, a 6H-1,3,4-Thiadiazine Derivative.
    Sirotenko VS; Spasov AA; Kucheryavenko AF; Gaidukova KA; Smirnov AV; Velikorodnaya YI
    Bull Exp Biol Med; 2024 May; 177(1):63-67. PubMed ID: 38954300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New oxadiazole derivatives showing partly antiplatelet, antithrombotic and serotonin antagonistic properties.
    Bethge K; Pertz HH; Rehse K
    Arch Pharm (Weinheim); 2005 Mar; 338(2-3):78-86. PubMed ID: 15736284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and antithrombotic activity of acetylsalicyl ferulic acid-coupling furoxans and nitrates].
    Zhou Z; Jiang LY; Zhang YH; Ji H; Sun Y; Peng SX
    Yao Xue Xue Bao; 2006 Nov; 41(11):1050-6. PubMed ID: 17262946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of new 1,3,4-thiadiazines on platelet aggregation in vitro and ex vivo].
    Logvinova OS; Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
    Eksp Klin Farmakol; 2010 Aug; 73(8):21-5. PubMed ID: 20919553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
    Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
    Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.